Workday Shares Rise as AI Integration Drives Margin Forecast Upgrade Understanding Debt Settlement How It Works and Potential Costs Citi Adjusts Bullish Stance on Sandisk SNDK With Revised Price Target BP Chairman Removed Amid Allegations of Bullying and Overbearing Conduct UK Government Unveils VAT Reduction on Theme Park Tickets and Childrens Meals to Ease CostofLiving Burden Indias Renewable Energy Sector Faces Grid Integration Headwinds in Q1 2026 Despite 275 GW Capacity Milestone SPMC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction ANGX Q1 2026 Earnings Narrowed Losses Surprise Analysts as Stock Responds MFICL Q1 2026 Earnings EPS Beat Supports Stable Performance Amid Steady Portfolio Royal Bank of Canada Q1 2026 Earnings EPS Beats Estimates Amid Resilient Banking Operations RCUS Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher MasTec MTZ Retreats From Resistance Technicals Signal Caution After 17 Decline Enlivex ENLV Edges Higher After Testing Key Support at 069 StoneCo Ltd STNE Edges Lower Amid Sector Pressure Key Support Levels in Focus Title Banco Bradesco ADR BBD Holds Steady Above Support Amid Modest Gains Morgan Stanley Emerging Markets Debt Fund Inc MSD Holds Steady Near Resistance Amid Modest Uptick Bridgewater Associates Shifts From Enterprise Software to AI Infrastructure Reducing SaaS Positions NVTS Q1 2026 Earnings Narrowed Loss Surpasses Estimates Shares Rally Nearly 20 ATT 5350 Notes due 2066 TBB Edge Lower as FixedIncome Market Searches for Direction Lionheart Holdings Warrant CUBWW Surges 27 as Price Tests Key Resistance NIP Group Inc NIPG Slides 534 Testing Key Support at 040 Evertec Inc EVTC Edges Higher as Shares Test Resistance Near 26 GeneDx Holdings Warrants Rally 1477 From Penny Level Yet Resistance Remains Stubborn Power Solutions International PSIX Edges Lower Consolidating Near Resistance at 45 SolarEdge Surges 148 Whats Driving the Solar Stocks Rally Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious